Publicaciones en las que colabora con José Luis Lanciego Pérez (9)

2024

  1. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2019

  1. Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings

    Journal of Neurology, Vol. 266, Núm. 10, pp. 2396-2405

2016

  1. Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys

    Biomaterials, Vol. 110, pp. 11-23

2008

  1. Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys

    Movement Disorders, Vol. 23, Núm. 5, pp. 708-715

2007

  1. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP

    Synapse, Vol. 61, Núm. 12, pp. 1006-1012

2004

  1. How does Parkinson's disease begin? The role of compensatory mechanisms (multiple letters)

    Trends in Neurosciences

  2. The origin of motor fluctuations in Parkinson's disease: Importance of dopaminergic innervation and basal ganglia circuits

    Neurology, Vol. 62, Núm. 1 SUPPL. 1

2000

  1. Pathophysiology of the basal ganglia in Parkinson's disease

    Trends in Neurosciences, Vol. 23, Núm. 10 SUPPL.

1998

  1. Multiple neuroanatomical tracing in primates

    Brain Research Protocols, Vol. 2, Núm. 4, pp. 323-332